Which has grown faster, MRNA or RL?

Over the past five years, RL grew revenue faster — MRNA at a -2.60% CAGR versus RL at 13.01%.

Does MRNA or RL pay a bigger dividend?

RL pays a dividend (0.90% yield) while MRNA does not currently pay one.

Is MRNA or RL more profitable?

RL runs the higher net margin — MRNA at -143.55% versus RL at 11.60%.

Which has been the better investment, MRNA or RL?

Over the past 5-year, RL delivered the higher annualized total return — MRNA at -23.87% versus RL at 17.77%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Ralph Lauren Corporation (RL)

RL leads on 8 of 10 compared metrics.

A side-by-side comparison of Moderna, Inc. and Ralph Lauren Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Ralph Lauren Corporation

$24.64B

$403.98Consumer Cyclical

Total return — MRNA vs RL

growth of $100 · last 8y

MRNA +168.3%RL +285.1%RL compounded faster

MRNA RL

MRNA vs RL: by the numbers

•RL is the larger company ($24.64B vs $20.47B market cap).
•RL is profitable (11.60% net margin) while MRNA runs a net loss (-143.55%).
•RL grew revenue faster over the past five years (13.01% vs -2.60% CAGR).
•RL pays a dividend (0.90% yield) while MRNA does not currently pay one.

Which is better, MRNA or RL?

Metric tally: MRNA 2 · RL 8

It depends on what you're optimizing for:

GrowthRL(faster 5Y revenue CAGR)

QualityRL(higher ROIC)

Metrics side by side

Valuation

Metric	MRNA	RL
P/E ratio	—	26.74
Forward P/E	—	22.03
P/S ratio	8.86	3.10●
P/B ratio	2.66●	8.86
PEG ratio	—	0.71
EV / EBITDA	—	22.22
FCF yield	—	2.96%

Profitability

Metric	MRNA	RL
Gross margin	-13.89%	69.87%●
Operating margin	-153.35%	14.53%●
Net margin	-143.55%	11.60%●
ROE	-43.12%	33.13%●
ROIC	-29.70%	19.62%●

Dividends

Metric	MRNA	RL
Dividend yield	—	0.90%
Payout ratio	—	23.67%

Growth (annualized)

Metric	MRNA	RL
Revenue CAGR (5Y)	-2.60%	13.01%●
EPS CAGR (5Y)	—	20.37%
FCF CAGR (5Y)	126.92%●	22.25%
Total return CAGR (5Y)	-23.87%	29.56%●

Frequently asked

Which is better, MRNA or RL?: It depends on your goal. growth: RL (faster 5Y revenue CAGR); quality: RL (higher ROIC). Across all compared metrics, RL leads 8 to 2.
Which has grown faster, MRNA or RL?: Over the past five years, RL grew revenue faster — MRNA at a -2.60% CAGR versus RL at 13.01%.
Does MRNA or RL pay a bigger dividend?: RL pays a dividend (0.90% yield) while MRNA does not currently pay one.
Is MRNA or RL more profitable?: RL runs the higher net margin — MRNA at -143.55% versus RL at 11.60%.
Which has been the better investment, MRNA or RL?: Over the past 5-year, RL delivered the higher annualized total return — MRNA at -23.87% versus RL at 17.77%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full RL analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio Ralph Lauren P/E ratio Moderna dividend yield Ralph Lauren dividend yield Moderna ROE Ralph Lauren ROE Moderna operating margin Ralph Lauren operating margin Moderna revenue growth Ralph Lauren revenue growth Moderna free cash flow Ralph Lauren free cash flow

Moderna & Ralph Lauren appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.